Bright Pink accelerates, deepens, and expands the impact of life-saving breast and ovarian health interventions for young women.

Bright Pink

Bright Pink | 5,505 followers on LinkedIn. saving lives from breast &amp; ovarian cancer by empowering women to know their risk &amp; manage their health proactively. | Bright Pink® helps to save lives from breast and ovarian cancer by empowering women to know their risk and manage their health proactively.

Founder of Moore Music.®️and HEAR TO PLAY®️ Producer/Writer/Artist & Music Management

Cassie Moore

COO @ PolyAPI

Jake Dreyfuss

Chair Radiation Medicine Phelps Hospital Associate Professor Donald and Barbara Zucker School of Medicine Hofstra University at Northwell Health

Janna Andrews

Owner at Lizzy Zawy Public Relations

Lizzy Zawy

Today, after 18 years of transforming breast and ovarian cancer awareness into action, Bright Pink proudly announces a $3.5M legacy gift to launch the Bright Pink Preventive Risk Outreach And Cascade Testing (PROACT) Program at Stanford Medicine. This transformative gift marks the close of our daily operations and entrusts the future of our mission to a team of leading experts in breast and ovarian health. Led by Dr. Allison Kurian and Dr. Jennifer Caswell-Jin of Stanford University, in collaboration with the University of Michigan, the PROACT Program will build on Bright Pink’s work using family health history to expand access to genetic testing. Through a proven online platform that makes sharing family health information—and acting on it—easier, faster, and more accessible than ever before, this program intends to empower families nationwide to understand and share their genetic risks and enable their loved ones to take life-saving action. As we reflect on all we’ve accomplished, we are filled with pride and gratitude for the Bright Pink community—the young women at the heart of our mission and the countless individuals and organizations who have championed it along the way. From our first 15 years serving millions of young women with life-saving education and resources to our recent work advancing health equity with our Mission Partners through the Bright Pink Venture Fund, our collective charge has remained the same: save young women's lives from breast and ovarian cancer through bold, innovative solutions. The PROACT Program intends to carry this legacy of life-saving impact forward and shape a better, brighter future for generations to come. For more information on Bright Pink's 18 years of impact, final chapter, and legacy gift visit: https://lnkd.in/gputsrks and visit https://proactprogram.org/ to visit the Bright Pink PROACT Program's new digital home on Stanford Medicine's site.

Metric
Company Name	Bright Pink
Symbol
MSH ID	ORG:BRIGHTPINK
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Nonprofit
Country	US
Stage
Employee Count
Website	brightpink.org
LinkedIn	bright-pink
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	96
Web Traffic Growth	-0.94
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BRIG

ORG:BRIGHTPINK

Bright Pink

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue